Business Description
Founded in 1915 and based in Valby, Denmark, H. Lundbeck A/S is a pharmaceutical company focused entirely on brain diseases, developing and selling medicines for conditions such as depression, schizophrenia, epilepsy, migraine, and Parkinson's disease across Europe, the United States, and other markets. The company markets a broad range of established treatments while also running an active pipeline of new drugs at various stages of clinical testing, targeting conditions from post-traumatic stress disorder to rare neurological diseases. Lundbeck also works with external partners, including a research collaboration with Contera Pharma to explore a newer class of medicines for serious neurological conditions.